TipRanks
Advertisement
Advertisement

HK:6955 Stock Latest News

Boan Biotech Wins CDE IND Nod for Novel PD-1/IL-2 Cancer Drug BA1203
Company AnnouncementsBoan Biotech Wins CDE IND Nod for Novel PD-1/IL-2 Cancer Drug BA1203
12d ago
6955
Boan Biotech Confirms Finance Lease Terms After Asset Revaluation
PremiumCompany Announcements
Boan Biotech Confirms Finance Lease Terms After Asset Revaluation
17d ago
6955
Boan Biotech Revenue Slides as R&D Spending Rises in Interim 2026
PremiumCompany Announcements
Boan Biotech Revenue Slides as R&D Spending Rises in Interim 2026
30d ago
6955
Shandong Boan Biotechnology Uses Finance Lease to Boost Working Capital
PremiumCompany Announcements
Shandong Boan Biotechnology Uses Finance Lease to Boost Working Capital
30d ago
6955
Shandong Boan Wins CDE Nod for Novel Bispecific IBD Antibody BA2201
PremiumCompany Announcements
Shandong Boan Wins CDE Nod for Novel Bispecific IBD Antibody BA2201
1M ago
6955
Shandong Boan Biotech Sets Board Meeting to Approve 2026 Interim Results and Mull Dividend
PremiumCompany AnnouncementsShandong Boan Biotech Sets Board Meeting to Approve 2026 Interim Results and Mull Dividend
1M ago
6955
Shandong Boan Warns of Interim Loss as R&D Spend Surges
Premium
Company Announcements
Shandong Boan Warns of Interim Loss as R&D Spend Surges
1M ago
6955
Boan Biotechnology Advances First-in-Class CD228 ADC With Positive Early Trial Data
Premium
Company Announcements
Boan Biotechnology Advances First-in-Class CD228 ADC With Positive Early Trial Data
1M ago
6955
Shandong Boan Files for Brazil Approval of EYLEA Biosimilar BA9101
PremiumCompany Announcements
Shandong Boan Files for Brazil Approval of EYLEA Biosimilar BA9101
2M ago
6955
Shandong Boan Wins CDE Nod for Next-Gen PD-1/IL-2 Cancer Drug BA1203
PremiumCompany Announcements
Shandong Boan Wins CDE Nod for Next-Gen PD-1/IL-2 Cancer Drug BA1203
3M ago
6955
Shandong Boan Wins CDE Nod for Phase II Lung Cancer Trial of Novel Immunotherapy Combo
PremiumCompany Announcements
Shandong Boan Wins CDE Nod for Phase II Lung Cancer Trial of Novel Immunotherapy Combo
3M ago
6955
Shandong Boan Wins Shareholder Backing for All AGM Resolutions and Share Mandates
PremiumCompany Announcements
Shandong Boan Wins Shareholder Backing for All AGM Resolutions and Share Mandates
3M ago
6955
Shandong Boan Licenses Trulicity Biosimilar BA5101 for U.S. Market
PremiumCompany AnnouncementsShandong Boan Licenses Trulicity Biosimilar BA5101 for U.S. Market
4M ago
6955
Shandong Boan Files for U.S. Approval of Denosumab Biosimilars as Global Push Accelerates
Premium
Company Announcements
Shandong Boan Files for U.S. Approval of Denosumab Biosimilars as Global Push Accelerates
4M ago
6955
Shandong Boan Biotech Sets 2026 AGM With Expanded Share Issuance Mandate on Agenda
Premium
Company Announcements
Shandong Boan Biotech Sets 2026 AGM With Expanded Share Issuance Mandate on Agenda
4M ago
6955
Boan Biotech Wins New China Approval for Denosumab Biosimilar, Accelerates Global Push
PremiumCompany Announcements
Boan Biotech Wins New China Approval for Denosumab Biosimilar, Accelerates Global Push
4M ago
6955
Shandong Boan Biotechnology Launches HK$200 Million Share Buyback Plan
PremiumCompany Announcements
Shandong Boan Biotechnology Launches HK$200 Million Share Buyback Plan
5M ago
6955
Shandong Boan Biotechnology Seeks Shareholder Nod for New RSU Incentive Scheme
PremiumCompany Announcements
Shandong Boan Biotechnology Seeks Shareholder Nod for New RSU Incentive Scheme
5M ago
6955
Shandong Boan Gains CDE Nod for Phase II Combo Trial in NSCLC
PremiumCompany Announcements
Shandong Boan Gains CDE Nod for Phase II Combo Trial in NSCLC
5M ago
6955
Shandong Boan Announces Leadership Changes as R&D Chief Retires
PremiumCompany AnnouncementsShandong Boan Announces Leadership Changes as R&D Chief Retires
6M ago
6955
Shandong Boan Biotechnology Updates Board and Committee Structure
Premium
Company Announcements
Shandong Boan Biotechnology Updates Board and Committee Structure
6M ago
6955
Shandong Boan Boosts 2025 Revenue as Commercial Push Lifts Costs
Premium
Company Announcements
Shandong Boan Boosts 2025 Revenue as Commercial Push Lifts Costs
6M ago
6955

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >